{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:26Z","timestamp":1787071526334,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Muscle-invasive bladder cancer (MIBC) is associated with poor survival outcomes despite radical cystectomy (RC), creating a clinical need for simple and reliable prognostic biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The CALLY index, a composite biomarker derived from serum C-reactive protein (CRP), albumin, and lymphocyte counts, reflects systemic inflammation, nutritional status, and immune function. Its prognostic utility in MIBC has not been fully elucidated. To evaluate the prognostic value of the CALLY index in predicting overall survival (OS) and disease-free survival (DFS) in patients undergoing RC for non-metastatic MIBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this retrospective cohort study, 134 patients who underwent RC for non-metastatic MIBC between February 2014 and January 2024 were included. Patients who received neoadjuvant chemotherapy, had secondary malignancies, or active infections were excluded. The CALLY index was calculated as follows: (Albumin [g\/dL] \u00d7 Lymphocyte count [10\u2079\/L])\/CRP [mg\/dL] \u00d710\u2074. Kaplan\u2013Meier and receiver operating characteristic curve analyses were used to evaluate survival outcomes and the predictive performance of the index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients with a CALLY index of \u22651.33 had significantly longer OS (median 62 vs. 29 months,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), and a cut-off of \u22651.11 was predictive of improved DFS (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.004). The index demonstrated moderate discriminative ability (AUC: 0.682 for OS; 0.647 for DFS). CRP and albumin were independent prognostic factors, whereas lymphocyte count was not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The CALLY index may serve as a valuable prognostic tool in patients with non-metastatic MIBC undergoing RC. Its incorporation into clinical risk stratification models could enhance individualized treatment planning. Prospective studies are warranted to validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_397_25","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:00:18Z","timestamp":1758992418000},"page":"1090-1096","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Impact of the CALLY Index in Predicting Overall Survival and Disease-Free Survival in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer"],"prefix":"10.4103","volume":"28","author":[{"given":"M","family":"Aky\u00fcz","sequence":"first","affiliation":[{"name":"Department of Urology, Haydarpa\u015fa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kayar","sequence":"additional","affiliation":[{"name":"Department of Urology, Haydarpa\u015fa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"\u00d6zsoy","sequence":"additional","affiliation":[{"name":"Department of Urology, \u00d6zel \u00dcnye \u00c7ak\u0131rtepe Hospital, Ordu, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130","family":"Artuk","sequence":"additional","affiliation":[{"name":"Department of Urology, Haydarpa\u015fa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kayar","sequence":"additional","affiliation":[{"name":"Department of Urology, Haydarpa\u015fa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tokuc","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Park Goztepe Hospital Complex, Bahcesehir University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: A systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-5394.2002.106011.x","article-title":"Bladder cancer: Epidemiology, diagnosis, and management","volume":"10","author":"Pashos","year":"2002","journal-title":"Cancer Pract"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3390\/cancers15071937","article-title":"Efficacy of Different Bacillus of Calmette-Gu\u00e9rin (BCG) strains on recurrence rates among intermediate\/high-risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-arm study systematic review, cumulative and network meta-analysis","volume":"15","author":"Del Giudice","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"R5-20260420","first-page":"e50646","article-title":"Comparative outcomes of radical cystectomy in muscle-invasive bladder cancer: A systematic review and meta-analysis","volume":"15","author":"Waraich","year":"2023","journal-title":"Cureus"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R8-20260420","first-page":"287","article-title":"Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy","volume":"75","author":"Lei","year":"2022","journal-title":"Arch Esp Urol"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hpb.2021.06.414","article-title":"Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma","volume":"24","author":"Iida","year":"2022","journal-title":"HPB (Oxford)"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1002\/jcp.28252","article-title":"Inflammatory cytokines in bladder cancer","volume":"234","author":"Shadpour","year":"2019","journal-title":"J Cell Physiol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"916850","DOI":"10.3389\/fonc.2022.916850","article-title":"The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Oncol"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"104352","DOI":"10.1016\/j.critrevonc.2024.104352","article-title":"C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis","volume":"197","author":"Fujiwara","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00345-020-03291-z","article-title":"The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: A systematic review of the literature","volume":"39","author":"Ornaghi","year":"2021","journal-title":"World J Urol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bju.12405","article-title":"Preoperative serum albumin is associated with mortality and complications after radical cystectomy","volume":"113","author":"Garg","year":"2014","journal-title":"BJU Int"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/all.13311","article-title":"AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer","volume":"73","author":"Jensen-Jarolim","year":"2018","journal-title":"Allergy"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3389\/fonc.2019.00960","article-title":"Higher levels of pre-operative peripheral lymphocyte count is a favorable prognostic factor for patients with stage I and II rectal cancer","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"119","DOI":"10.31768\/2312-8852.2018.40(2):119-123","article-title":"Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer","volume":"40","author":"Yakovlev","year":"2018","journal-title":"Exp Oncol"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41598-023-51109-w","article-title":"Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery","volume":"14","author":"Feng","year":"2024","journal-title":"Sci Rep"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"112191","DOI":"10.1016\/j.nut.2023.112191","article-title":"Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer","volume":"116","author":"Zhang","year":"2023","journal-title":"Nutrition"},{"key":"R20-20260420","first-page":"533","article-title":"The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer","volume":"31","author":"Liu","year":"2023","journal-title":"Support Care Cancer"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"e37197","DOI":"10.1016\/j.heliyon.2024.e37197","article-title":"Associations of C-reactive protein-albumin-lymphocyte (CALLY) index with cardiorenal syndrome: Insights from a population-based study","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1464-410X.2010.09417.x","article-title":"Management of elderly patients with urothelial carcinoma of the bladder: Guideline concordance and predictors of overall survival","volume":"106","author":"Bolenz","year":"2010","journal-title":"BJU Int"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jso.24521","article-title":"Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy","volume":"115","author":"D\u2019Andrea","year":"2017","journal-title":"J Surg Oncol"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11255-023-03812-w","article-title":"Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer","volume":"56","author":"Kayar","year":"2024","journal-title":"Int Urol Nephrol"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_397_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:31Z","timestamp":1787068051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_397_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_397_25","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-06-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}